Aimspro is a product derived from the serum of immunised goats. Daval have, until now, used a flock of goats based in the USA. The recent case of suspected “Mad Cow Disease” in North America has led Daval International Limited to consider the safest source of serum for all future production, especially as the USA is now deemed to be a Category 3 risk area.
The medication has an impeccable safety record (thanks to Professor Angus Dalgleish) and Daval regards long term patient safety as it’s paramount concern. All serum that has previously undergone manufacture for human use was collected well prior to the notification of this disease in the USA. The Daval Board has decided that as a matter of prudence all serum will now be obtained from non-USA sources, specifically from one of the Category 1 areas in the Southern Hemisphere regarded as free of Scrapie and Bovine Spongioform Encephalopathy (BSE). Even though this is a costly decision, no compromise will be made on safety.
The regulatory authorities in the UK and Australia have been informed and regrettably Daval has closed down its operation in the United States. Regrettably, all raw serum stock is now classed as hazardous and treated as such. It is hoped that an announcement concerning the likely date for the eventual availability of “specials” will be made within several weeks.
http://www.davalinternational.com/marku ... 180805.cfm